Alpine Immune Sciences Inc logo

Alpine Immune Sciences Inc

NAS:ALPN (USA)  
$ 39.64 +0.99 (+2.56%) 04:00 PM EST
At Loss
P/B:
7.30
Volume:
1.46M
Avg Vol (2M):
1.22M
Also Trade In:
Volume:
1.46M
At Loss
Avg Vol (2M):
1.22M

Business Description

Description
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company dedicated to discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its approach includes a proprietary scientific platform that converts native immune system proteins into differentiated, multi-targeted therapeutics. Its pipeline candidates are; ALPN-303, or povetacicept, is a dual antagonist of the B cell activating factor, or BAFF, and a proliferation-inducing ligand, or APRIL, cytokines, which play key roles in the activation, development, and survival of B cells, and ALPN-101, or acazicolcept, is a dual Inducible T cell Costimulator, or ICOS, and CD28 antagonist intended for the treatment of autoimmune and inflammatory diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 33.03
Equity-to-Asset 0.86
Debt-to-Equity 0.03
Debt-to-EBITDA -0.32
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 29.12
Distress
Grey
Safe
Beneish M-Score -1.33
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 54.05
9-Day RSI 56.88
14-Day RSI 59.75
6-1 Month Momentum % 207.35
12-1 Month Momentum % 413.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.86
Quick Ratio 7.86
Cash Ratio 7.8
Days Sales Outstanding 2.15

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -36.4
Shareholder Yield % 0.21

Financials (Next Earnings Date:2024-05-10 Est.)

ALPN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ALPN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Alpine Immune Sciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 58.876
EPS (TTM) ($) -0.64
Beta 1.34
Volatility % 72.96
14-Day RSI 59.75
14-Day ATR ($) 2.195646
20-Day SMA ($) 37.389
12-1 Month Momentum % 413.71
52-Week Range ($) 6.71 - 42.8799
Shares Outstanding (Mil) 65.55

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Alpine Immune Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Alpine Immune Sciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Alpine Immune Sciences Inc Frequently Asked Questions

What is Alpine Immune Sciences Inc(ALPN)'s stock price today?
The current price of ALPN is $39.64. The 52 week high of ALPN is $42.88 and 52 week low is $6.71.
When is next earnings date of Alpine Immune Sciences Inc(ALPN)?
The next earnings date of Alpine Immune Sciences Inc(ALPN) is 2024-05-10 Est..
Does Alpine Immune Sciences Inc(ALPN) pay dividends? If so, how much?
Alpine Immune Sciences Inc(ALPN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1